XENCOR (XNCR) Covered Calls

Xencor Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs.

You can sell covered calls on XENCOR to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for XNCR (prices last updated Fri 4:16 PM ET):

XENCOR (XNCR) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
39.96 -0.08 39.96 39.96 103K - 2.2B
Covered Calls For XENCOR (XNCR)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Sep 21 40 0.80 39.16 2.0% 20.3%
Nov 16 40 1.80 38.16 4.7% 18.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Xencor, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. The company uses proprietary XmAb technology platform to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, asthma, cancer, and other conditions. Xencor was founded Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.